Associação entre os níveis de quimiocinas periféricas e déficits cognitivos no acidente vascular cerebral isquêmico agudo leve a moderado: um estudo transversal
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Ischemic stroke (IS) is a frequent cause of cognitive impairment, even in
clinically mild to moderate cases. Neuroinflammation, mediated by circulating
chemokines and inflammatory proteins, has been proposed as a link between acute
ischemic injury and persistent cognitive deficits. In this context, serum biomarkers are
particularly attractive as they avoid invasive sampling, allow serial assessment and
fall within the therapeutic window of IS, providing a real opportunity for risk
stratification and early cognitive prognosis. Despite this, the relationship between the
serum profile of these mediators in the acute phase and cognitive performance
remains poorly characterized in patients with mild to moderate IS. This study aimed
to investigate the association between serum levels of chemokines and inflammatory
proteins and cognitive performance in patients in the acute phase of mild to moderate
IS. This was a cross-sectional study with a quantitative approach, based on data
collected between 2019 and 2021 at the Hospital Metropolitano Odilon Behrens
(HOB), a public regional referral center for neurological urgencies and the main entry
point for stroke cases in Belo Horizonte (MG, Brazil) and its metropolitan area. A total
of 42 participants were included: 21 patients with IS (NIHSS score 0 to 10) and 21
healthy controls matched by sex, age and education. Participants were assessed
using the Mini-Mental State Examination (MMSE), the Frontal Assessment Battery
(FAB) and the Visual Memory Test (VMT). Peripheral blood samples were collected
concurrently with cognitive testing for serum quantification of CCL2, CCL3, CCL4,
CCL5, CCL7, CCL11, CCL22, CXCL8, MIF, MPO and Lipocalin-2 (LCN2) by a beadbased multiplex immunoassay. Statistical analyses included the Mann-Whitney and
chi-square tests, simple linear regression, Spearman correlation and Receiver
Operating Characteristic (ROC) curve analysis. The post-IS group showed reduced
serum levels of CCL3, CCL4, CCL5 and CXCL8 and elevated levels of LCN2
compared with the control group. LCN2 was positively associated with neurological
severity (NIHSS) and negatively associated with FAB performance and with
immediate memory in the VMT, whereas CCL3, CCL5 and CXCL8 showed an
inverse association with NIHSS. In the ROC analyses, LCN2 (area under the curve,
AUC = 1.00) and CXCL8 (AUC = 0.94) stood out in discriminating between groups.
Within the post-IS group, MIF discriminated patients with worse FAB performance
(AUC = 0.82) and MPO discriminated patients with worse immediate memory in the
10
VMT (AUC = 0.83). The findings support the hypothesis that the serum profile of
chemokines and inflammatory proteins in the acute phase of mild to moderate IS are
related to neurological severity and to specific cognitive domains, highlighting LCN2
as a marker of severity and MIF and MPO as potential markers of executive and
memory impairment, respectively.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

